HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of adrenocorticotrophic hormone analog to minimize brain injury.

AbstractSTUDY OBJECTIVES:
To investigate the effects of a vasoactive analog of adrenocorticotrophic hormone (GMM2) on time-dependent disturbances in regional cerebral blood flow, permeability-capillary surface area products, and intracranial pressure in a rat model of moderate concussion/brain injury.
SETTING AND DESIGN:
Regional permeability-capillary surface area products and cerebral blood flow were measured at two hours after trauma. Intracranial pressure was monitored for 120 hours after trauma.
SUBJECTS:
Male Wistar rats (330 to 430 g) (regional cerebral blood flow studies, n = 35; permeability-capillary surface area product studies, n = 36; intracranial pressure studies, n = 32).
INTERVENTIONS:
Post-traumatic subcutaneous administration of nanomolar concentrations of GMM2 (31 nmol per rat).
MEASUREMENTS AND MAIN RESULTS:
Untreated trauma acutely increased average brain permeability-capillary surface area products for sucrose and decreased average brain cerebral blood flow. Moreover, it produced marked and prolonged increases in intracranial pressure. Post-traumatic subcutaneous administration of nanomolar concentrations of GMM2 effectively reduced the early hypoperfusion, blood-brain barrier leakiness, and pathologic elevation of intracranial pressure.
CONCLUSION:
Post-traumatic administration of GMM2, in nanomolar amounts, can prevent or reverse significantly the serious cerebrovascular sequelae of moderate head injury in this animal model. In view of its potency, low toxicity, and other neuroprotective properties, in both rats and human beings, these data suggest that GMM2 may have considerable clinical benefits in the treatment of central nervous system trauma.
AuthorsH Goldman, M Morehead, S Murphy
JournalAnnals of emergency medicine (Ann Emerg Med) Vol. 22 Issue 6 Pg. 1035-40 (Jun 1993) ISSN: 0196-0644 [Print] United States
PMID8389101 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Neuropeptides
  • Adrenocorticotropic Hormone
Topics
  • Adrenocorticotropic Hormone (analogs & derivatives, therapeutic use)
  • Animals
  • Blood-Brain Barrier (drug effects)
  • Brain Injuries (drug therapy)
  • Cell Membrane Permeability (drug effects)
  • Cerebrovascular Circulation (drug effects)
  • Intracranial Pressure (drug effects)
  • Male
  • Motor Activity (drug effects)
  • Neuropeptides (therapeutic use)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: